Skip to Main Content

Author Details

Andr?? Haman
Universite de Montreal, Institute for Research in Immunology and Cancer
1988
25
18
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35589701Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.Nat Commun2022
35401501Monoallelic <i>Heb/Tcf12</i> Deletion Reduces the Requirement for NOTCH1 Hyperactivation in T-Cell Acute Lymphoblastic Leukemia.Front Immunol2022
31196146Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.J Exp Clin Cancer Res2019
29062045Evolution of AF6-RAS association and its implications in mixed-lineage leukemia.Nat Commun2017
28096188Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylate Gab2 To Promote a Negative-Feedback Loop That Attenuates Phosphoinositide 3-Kinase/Akt Signaling.Mol Cell Biol2017
26764384The LMO2 oncogene regulates DNA replication in hematopoietic cells.Proc Natl Acad Sci U S A2016
27797342High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.J Clin Invest2016
23898169RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.Proc Natl Acad Sci U S A2013
19850742Scl regulates the quiescence and the long-term competence of hematopoietic stem cells.Blood2010
17283046c-Jun homodimers can function as a context-specific coactivator.Mol Cell Biol2007
17878155Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction.J Biol Chem2007
11507083Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.Cancer Res2001
10523632Targeted disruption of the murine fps/fes proto-oncogene reveals that Fps/Fes kinase activity is dispensable for hematopoiesis.Mol Cell Biol1999
10454582The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells.Mol Cell Biol1999
10567387Molecular determinants of the granulocyte-macrophage colony-stimulating factor receptor complex assembly.J Biol Chem1999
9166423Crucial role of the residue R280 at the F'-G' loop of the human granulocyte/macrophage colony-stimulating factor receptor alpha chain for ligand recognition.J Exp Med1997
8874187Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor.Blood1996
8505314The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model.J Biol Chem1993
1315776Role of protein kinase C and the Na+/H+ antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and interleukin-3.J Biol Chem1992
2201826IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in supporting blast proliferation.Leukemia1990
2153034Characterization of granulocyte-macrophage colony-stimulating factor receptor on the blast cells of acute myeloblastic leukemia.Blood1990
2664067Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.J Exp Med1989
2835051Inhibitory effect of the regulatory subunit of type I cAMP-dependent protein kinase on phosphoprotein phosphatase.Biochem Int1988
3042049Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia.Blood1988
3261773Interleukin 1 enhances growth factor-dependent proliferation of the clonogenic cells in acute myeloblastic leukemia and of normal human primitive hemopoietic precursors.J Exp Med1988
  • 1 - 25 of 25

Recommended Authors

Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 0
Antonella Sassano
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Robert S Welner
University of Alabama at Birmingham
Career Start Year 2002
Number of shared co-authors 1
Dorian LaTocha
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 1
Heather M Rooke
Broad Institute of Harvard and MIT
Career Start Year 1999
Number of shared co-authors 0
Shinichiro Takahashi
Tohoku Medical and Pharmaceutical University Hospital.
Career Start Year 1998
Number of shared co-authors 0
Carl Anthony Blau
Center for Cancer Innovation, University of Washington
Career Start Year 1991
Number of shared co-authors 0
Johanna Ten Hoeve
California Nanosystems Institute, University of California los angeles
Career Start Year 1990
Number of shared co-authors 1
Claus Nerlov
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1990
Number of shared co-authors 1
Geoffrey Neale
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Career Start Year 1986
Number of shared co-authors 3
Tarik M??r??y
Institut de recherches cliniques de Montreal
Career Start Year 1985
Number of shared co-authors 1
Thomas Decker
University of Vienna
Career Start Year 1985
Number of shared co-authors 0
Daniel C Link
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 1
Timothy J Ley
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 2
Nancy A Speck
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1981
Number of shared co-authors 1
Stefan Burdach
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
Richard J Bram
Mayo Clinic College of Medicine
Career Start Year 1980
Number of shared co-authors 0
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 1
Robert E Lewis
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 1979
Number of shared co-authors 0
Martine F Roussel
St. Jude Children's Research Hospital
Career Start Year 1977
Number of shared co-authors 0
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Career Start Year 1976
Number of shared co-authors 1
Peter A Kiener
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Howard A Young
Center for Cancer Research, National Cancer Institute
Career Start Year 1975
Number of shared co-authors 0
Hiroshi Handa
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 2
Owen N Witte
University of California los angeles
Career Start Year 1972
Number of shared co-authors 1
Tak W Mak
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 1
Charles J Sherr
St. Jude Children's Research Hospital
Career Start Year 1968
Number of shared co-authors 0
Grover C Bagby
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 1966
Number of shared co-authors 0

Collaborators

Trang Hoang
Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University
Co-authored papers 24
Mathieu Tremblay
Universite de Montreal, Institute for Research in Immunology and Cancer
Co-authored papers 6
Guy Sauvageau
Universite de Montreal
Co-authored papers 4
Diogo F T Veiga
University of Campinas (UNICAMP)
Co-authored papers 4
Benoit Grondin
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers 3
Bastien Gerby
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Co-authored papers 2
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Co-authored papers 2
Philippe P Roux
IRIC - University of Montreal
Co-authored papers 2
Anne Marinier
Institute for Research in Immunology and Cancer
Co-authored papers 2
Elizabeth Ottoni
Universite de Montreal
Co-authored papers 2
Genevi??ve Lavoie
Institute for Research in Immunology and Cancer (IRIC)
Co-authored papers 2
Marie-Jos??e H??bert
Universite de Montreal
Co-authored papers 2
Antoine M??ant
Institute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Co-authored papers 1
Kolja Eppert
McGill University
Co-authored papers 1
Toshio Kitamura
The University of Tokyo.
Co-authored papers 1
Ema Flores-D??az
Institute of Research in Immunology and Cancer, Universite de Montreal
Co-authored papers 1
Sylvain Meloche
Institute for Research in Immunology and Cancer
Co-authored papers 1
Chantal Richer
CHU Sainte-Justine Research Center
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
No??l J-M Raynal
Sainte-Justine University Hospital Research Center
Co-authored papers 1
Gabrielle McInnes
Departement de pharmacologie et physiologie, Universite de Montreal
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Daniel Sinnett
Sainte-Justine University Hospital Research Center
Co-authored papers 1
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
Gregory Armaos
Departement de pharmacologie et physiologie, Universite de Montreal
Co-authored papers 1
Milena Kosic
Leslie Dan Faculty of Pharmacy and Department of Biochemistry, University of Toronto
Co-authored papers 1
Moutih Rafei
Universite de Montreal
Co-authored papers 1
Maxime Caron
Centre Hospitalier Universitaire Sainte-Justine
Co-authored papers 1
Sami Nourreddine (CM4AI)
University of California San Diego
Co-authored papers 1
Julianne Ouellette
Co-authored papers 1
Release 1.2